Free Float -
Shares Float -
Shares Outstanding 5,91 M
VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF ETF · US92189F6925 · PPH (FUND) VanEck · TER 0,36 % · USA · Financial Services — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF
No Price
18.05.2026 20:00
Current Prices from VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 NASDAQ |
PPH
|
USD
|
18.05.2026 20:00
|
101,12 USD
| 0,28 USD
+0,28 %
|
 IEX |
PPH
|
USD
|
18.05.2026 19:59
|
101,14 USD
| 0,30 USD
+0,29 %
|
Share Float & Liquidity
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 64,99 % |
| Other | 34,65 % |
Largest Positions(26)
Updated on 18.05.2026 19:17:26
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| LLY | US5324571083 | 532457108 | Eli Lilly & Co | 190.368 | 191,31 M EUR | 20,79 % |
| NVS | US66987V1098 | 66987V109 | Novartis Ag | 663.346 | 99,35 M EUR | 10,80 % |
| MRK | US58933Y1055 | 58933Y105 | Merck & Co Inc | 757.675 | 85,93 M EUR | 9,34 % |
| NVO | US6701002056 | 670100205 | Novo Nordisk A/S | 1,23 M IDX | 56,13 M EUR | 6,10 % |
| PFE | US7170811035 | 717081103 | Pfizer Inc | 1,74 M IDX | 44,88 M EUR | 4,88 % |
| BMY | US1101221083 | 110122108 | Bristol-Myers Squibb Co | 718.001 | 40,76 M EUR | 4,43 % |
| GSK | US37733W2044 | 37733W204 | Gsk Plc | 780.851 | 39,43 M EUR | 4,29 % |
| SNY | US80105N1054 | 80105N105 | Sanofi Sa/France | 918.880 | 39,37 M EUR | 4,28 % |
| AZN | GB0009895292 | G0593M107 | Astrazeneca Plc | 208.886 | 38,64 M EUR | 4,20 % |
| JNJ | US4781601046 | 478160104 | Johnson & Johnson | 167.091 | 38,56 M EUR | 4,19 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 59,61 % |
| United Kingdom and Northern Ireland | 11,41 % |
| Switzerland | 10,80 % |
| Denmark | 6,10 % |
| France | 4,28 % |
| Israel | 3,38 % |
| Japan | 2,88 % |
| Ireland | 1,07 % |
| Canada | 0,11 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Healthcare | 99,64 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Drug Manufacturers - General | 73,15 % |
| Drug Manufacturers - Specialty & Generic | 13,05 % |
| Medical - Pharmaceuticals | 5,55 % |
| Medical - Equipment & Services | 3,74 % |
| Medical - Distribution | 3,15 % |
| Biotechnology | 1,00 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 87,40 % |
| EUR | 7,93 % |
| GBP | 4,20 % |
| CAD | 0,11 % |
Invested Funds
The following funds have invested in VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF:
Fund | Vol. in million 76,69 | Percentage (%) 0,04 % |
Fund | Vol. in million 296,72 | Percentage (%) 0,04 % |
Fund | Vol. in million 35,82 | Percentage (%) 0,01 % |
Company Profile for VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Fund Master Data
Issuer VanEck
Asset Class ETF
Name VanEck Pharmaceutical ETF
Asset Class Equity
Fund Currency USD
Total Expense Ratio (TER) 0,36 %
Domicile United States
Website vaneck.com
Fund Key Figures
Fund Size 232.719,38 EUR
NAV 100.83
AUM 911,36 M EUR
Avg. Daily Volume 350.332
Investment Strategy
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Updated on 18.05.2026 14:50:56
Company Data
Name VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF
Company VanEck Pharmaceutical ETF
Symbol PPH
Primary Exchange 
Fondsgesellschaft
Fondsgesellschaft
ISIN US92189F6925
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 595 Mio
Country USA
Currency USD
Employees -
IPO Date 2000-02-01
Dividends from 'VANECK VECTORS ETF TRUST - VANECK VECTORS PHARMACEUTICAL ETF'
| Ex-Date | Dividend per Share |
|---|---|
| 01.04.2026 | 0,84 USD |
| 29.12.2025 | 0,31 USD |
| 01.10.2025 | 0,39 USD |
| 01.07.2025 | 0,61 USD |
| 01.04.2025 | 0,52 USD |
| 27.12.2024 | 0,41 USD |
| 01.10.2024 | 0,41 USD |
| 01.07.2024 | 0,36 USD |
| 01.04.2024 | 0,53 USD |
| 27.12.2023 | 0,31 USD |
Stock Splits
| Date | Split |
|---|---|
| 14.02.2012 | 2:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | PPH |